An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
- Conditions
- Parkinson's Disease (PD)
- Registration Number
- NCT05916157
- Lead Sponsor
- AbbVie
- Brief Summary
Parkinson's disease (PD) is a neurological condition, which affects the brain. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is to assess how safe and effective ABBV-951 is in treating participants with Parkinson's disease in real world setting.
ABBV-951 is an approved drug being developed for the treatment of PD in Japan. Approximately 250 adult participants over 15 years with a diagnosis of PD who are prescribed ABBV-951 by their physicians will be enrolled in this study across Japan.
Participants will receive ABBV-951 as prescribed their physician and followed for 52 weeks.
There is expected to be no additional burden for participants in this trial. Study visits may be conducted on-site or virtually as per standard of care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
- Diagnosed with advanced Parkinson's disease (aPD).
- Prescribed ABBV-951 as physicians' decision according to the approved label for treatment of aPD.
- Given informed consent (or by her/his legal representative, if it's a requirement from the participating hospital/clinic) for participating this study.
- Prior treatment with ABBV-951 for PD.
- Currently participating in interventional clinical trials.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of Participants Experiencing Infusion Site Infections Up to 52 Weeks Percentage of participants with infusion site infections following the commencement of ABBV-951 will be assessed.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (15)
Municipal Toyonaka Hospital /ID# 271277
🇯🇵Toyonaka, Japan
Saiseikai Matsuyama Hospital /ID# 276259
🇯🇵Matsuyama, Ehime, Japan
University Hospital Kyoto Prefectural University of Medicine /ID# 267445
🇯🇵Kyoto-shi, Kyoto, Japan
National Hospital Organization Asahikawa Medical Center /ID# 269115
🇯🇵Asahikawa, Hokkaido, Japan
Ryugasaki Saiseikai Hospital /ID# 264435
🇯🇵Ryugasaki, Ibaraki, Japan
University of Tsukuba Hospital /ID# 268353
🇯🇵Tsukuba-shi, Ibaraki, Japan
Okatsu Hospital /ID# 262781
🇯🇵Kagoshima-shi, Kagoshima, Japan
Sendai Nishitaga National Hospital /ID# 268349
🇯🇵Sendai, Miyagi, Japan
Shiga University of Medical Science Hospital /ID# 265637
🇯🇵Otsu, Shiga, Japan
Dokkyo Medical University Hospital /ID# 269116
🇯🇵Mibu, Tochigi, Japan
Juntendo University Hospital /ID# 264438
🇯🇵Bunkyo-ku, Tokyo, Japan
Nitobe Memorial Nakano General Hospital /ID# 275668
🇯🇵Nakano-ku, Tokyo, Japan
National Center of Neurology and Psychiatry - Kodaira /ID# 267372
🇯🇵Xiaoping City, Tokyo, Japan
National Hospital Organization Utano Hospital /ID# 268350
🇯🇵Kyoto, Japan
Okayama Neurology Clinic /ID# 269117
🇯🇵Okayama, Japan